205 related articles for article (PubMed ID: 21493703)
1. Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.
Dunér P; To F; Beckmann K; Björkbacka H; Fredrikson GN; Nilsson J; Bengtsson E
Cardiovasc Res; 2011 Aug; 91(3):528-36. PubMed ID: 21493703
[TBL] [Abstract][Full Text] [Related]
2. Immune responses against aldehyde-modified laminin accelerate atherosclerosis in Apoe-/- mice.
Dunér P; To F; Berg K; Alm R; Björkbacka H; Engelbertsen D; Fredrikson GN; Nilsson J; Bengtsson E
Atherosclerosis; 2010 Oct; 212(2):457-65. PubMed ID: 20810111
[TBL] [Abstract][Full Text] [Related]
3. Immunologic response enhances atherosclerosis-type 1 helper T cell (Th1)-to-type 2 helper T cell (Th2) shift and calcified atherosclerosis in Bacillus Calmette-Guerin (BCG)-treated apolipoprotein E-knockout (apo E-/-) mice.
Shibata Y; Ohata H; Yamashita M; Tsuji S; Bradfield JF; Nishiyama A; Henriksen RA; Myrvik QN
Transl Res; 2007 Feb; 149(2):62-9. PubMed ID: 17240316
[TBL] [Abstract][Full Text] [Related]
4. Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.
Sasaki N; Yamashita T; Takeda M; Shinohara M; Nakajima K; Tawa H; Usui T; Hirata K
Circulation; 2009 Nov; 120(20):1996-2005. PubMed ID: 19884470
[TBL] [Abstract][Full Text] [Related]
5. Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression.
Fredrikson GN; Andersson L; Söderberg I; Dimayuga P; Chyu KY; Shah PK; Nilsson J
Autoimmunity; 2005 Mar; 38(2):171-9. PubMed ID: 16040338
[TBL] [Abstract][Full Text] [Related]
6. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
[TBL] [Abstract][Full Text] [Related]
7. Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE(-/-) mice through modulation of Th1/Th2 balance.
Cheng X; Chen Y; Xie JJ; Yao R; Yu X; Liao MY; Ding YJ; Tang TT; Liao YH; Cheng Y
J Mol Cell Cardiol; 2008 Aug; 45(2):168-75. PubMed ID: 18502445
[TBL] [Abstract][Full Text] [Related]
8. Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease.
Dunér P; To F; Alm R; Gonçalves I; Fredrikson GN; Hedblad B; Berglund G; Nilsson J; Bengtsson E
J Intern Med; 2009 May; 265(5):593-603. PubMed ID: 19226376
[TBL] [Abstract][Full Text] [Related]
9. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis.
Taleb S; Herbin O; Ait-Oufella H; Verreth W; Gourdy P; Barateau V; Merval R; Esposito B; Clément K; Holvoet P; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2691-8. PubMed ID: 17690315
[TBL] [Abstract][Full Text] [Related]
10. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice.
Mallat Z; Gojova A; Brun V; Esposito B; Fournier N; Cottrez F; Tedgui A; Groux H
Circulation; 2003 Sep; 108(10):1232-7. PubMed ID: 12912803
[TBL] [Abstract][Full Text] [Related]
11. Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice.
Wang L; Gao S; Xu W; Zhao S; Zhou J; Wang N; Yuan Z
J Mol Cell Cardiol; 2014 Jul; 72():20-7. PubMed ID: 24530901
[TBL] [Abstract][Full Text] [Related]
12. FcgammaRIIB inhibits the development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Zhao M; Wigren M; Dunér P; Kolbus D; Olofsson KE; Björkbacka H; Nilsson J; Fredrikson GN
J Immunol; 2010 Mar; 184(5):2253-60. PubMed ID: 20097865
[TBL] [Abstract][Full Text] [Related]
13. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.
Klingenberg R; Lebens M; Hermansson A; Fredrikson GN; Strodthoff D; Rudling M; Ketelhuth DF; Gerdes N; Holmgren J; Nilsson J; Hansson GK
Arterioscler Thromb Vasc Biol; 2010 May; 30(5):946-52. PubMed ID: 20167655
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine.
Wigren M; Kolbus D; Dunér P; Ljungcrantz I; Söderberg I; Björkbacka H; Fredrikson GN; Nilsson J
J Intern Med; 2011 May; 269(5):546-56. PubMed ID: 21114693
[TBL] [Abstract][Full Text] [Related]
15. Activation of immune responses against the basement membrane component collagen type IV does not affect the development of atherosclerosis in ApoE-deficient mice.
Vallejo J; Dunér P; To F; Engelbertsen D; Gonçalves I; Nilsson J; Bengtsson E
Sci Rep; 2019 Apr; 9(1):5964. PubMed ID: 30979943
[TBL] [Abstract][Full Text] [Related]
16. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
Zhou X; Paulsson G; Stemme S; Hansson GK
J Clin Invest; 1998 Apr; 101(8):1717-25. PubMed ID: 9541503
[TBL] [Abstract][Full Text] [Related]
17. The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.
Steinmetz M; Ponnuswamy P; Laurans L; Esposito B; Tedgui A; Mallat Z
Biochem Biophys Res Commun; 2015 Aug; 464(1):306-11. PubMed ID: 26116775
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice.
Erbel C; Chen L; Bea F; Wangler S; Celik S; Lasitschka F; Wang Y; Böckler D; Katus HA; Dengler TJ
J Immunol; 2009 Dec; 183(12):8167-75. PubMed ID: 20007582
[TBL] [Abstract][Full Text] [Related]
19. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.
Liu SL; Li YH; Shi GY; Tang SH; Jiang SJ; Huang CW; Liu PY; Hong JS; Wu HL
Cardiovasc Res; 2009 Apr; 82(1):161-9. PubMed ID: 19189960
[TBL] [Abstract][Full Text] [Related]
20. Exacerbation of type II collagen-induced arthritis in apolipoprotein E-deficient mice in association with the expansion of Th1 and Th17 cells.
Postigo J; Genre F; Iglesias M; Fernández-Rey M; Buelta L; Carlos Rodríguez-Rey J; Merino J; Merino R
Arthritis Rheum; 2011 Apr; 63(4):971-80. PubMed ID: 21225684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
